Yuto Nakajima

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 16

Top Topics

Systemic Lupus Erythematosus

Acute Kidney Injury

Top Venues

Haemophilia : the official journal of the World Federation of Hemophilia

International journal of hematology

Pediatrics international : official journal of the Japan Pediatric Society

This page only lists publications with an associated author ORCID identifier.

Publications

Mitsumasa Osuna, Yuto Nakajima, Kenichi Ogiwara, Keiji Nogami
Changes in coagulation potential over time after administration of recombinant activated factor VII in an emicizumab-treated hemophilia A patient with inhibitors. International journal of hematology (2024)
Yuto Nakajima, Akihisa Oda, Nemekhbayar Baatartsogt, Yuji Kashiwakura, Tsukasa Ohmori, Keiji Nogami
The combination of Asp519Val/Glu665Val and Lys1813Ala mutations in FVIII markedly increases coagulation potential. Blood advances 8 (15) (2024)
Koyo Yamada, Yuto Nakajima, Kenichi Ogiwara, Toshiyuki Sakai, Kazuyoshi Fukuda, Keiji Nogami
ROTEM could be useful for lupus anticoagulant hypoprothrombinemia syndrome. Pediatrics international : official journal of the Japan Pediatric Society 66 (1) (2024)
Yuto Nakajima, Akihisa Oda, Nemekhbayar Baatartsogt, Yuji Kashiwakura, Tsukasa Ohmori, Keiji Nogami
The combination of Asp519Val/Glu665Val and Lys1813Ala mutations in FVIII markedly increases coagulation potential. Blood advances (2024)
Koyo Yamada, Yuto Nakajima, Kenichi Ogiwara, Toshiyuki Sakai, Kazuyoshi Fukuda, Keiji Nogami
ROTEM could be useful for lupus anticoagulant hypoprothrombinemia syndrome. Pediatrics international : official journal of the Japan Pediatric Society 66 (1) (2024)
Yuto Nakajima, Akihisa Oda, Nemekhbayar Baatartsogt, Yuji Kashiwakura, Tsukasa Ohmori, Keiji Nogami
The combination of Asp519Val/Glu665Val and Lys1813Ala mutations in FVIII markedly increases coagulation potential. Blood advances 8 (15) (2024)
Yuto Nakajima, Akihisa Oda, Nemekhbayar Baatartsogt, Yuji Kashiwakura, Tsukasa Ohmori, Keiji Nogami
The combination of Asp519Val/Glu665Val and Lys1813Ala mutations in FVIII markedly increases coagulation potential. Blood advances 8 (15) (2024)
Masahiro Takeyama, Shoko Furukawa, Kenichi Ogiwara, Shinobu Tamura, Hitoshi Ohno, Satoshi Higasa, Naruto Shimonishi, Yuto Nakajima, Tomoko Onishi, Keiji Nogami
Coagulation potentials of plasma-derived factors VIIa and X mixture (Byclot ® ) evaluated by global coagulation assay in patients with acquired haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Kuniyoshi Mizumachi, Yuto Nakajima, Naruto Shimonishi, Shoko Furukawa, Kenichi Ogiwara, Masahiro Takeyama, Keiji Nogami
Hybrid human-porcine factor VIII proteins partially escape the inhibitory effects of anti-factor VIII inhibitor alloantibodies having A2 or C2 domain specificity. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Yuto Nakajima, Kenichi Ogiwara, Naruto Shimonishi, Shoko Furukawa, Masahiro Takeyama, Keiji Nogami
Intra-articular haemorrhage caused by reduced recovery of PEGylated recombinant factor VIII due to an anti-PEG antibody developed after mRNA-1273 SARS-CoV-2 vaccination in haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Naruto Shimonishi, Kenichi Ogiwara, Junko Yoshida, Kyoji Horie, Yuto Nakajima, Shoko Furukawa, Masahiro Takeyama, Keiji Nogami
Impaired factor V-related anticoagulant mechanisms and deep vein thrombosis associated with A2086D and W1920R mutations. Blood advances (2023)
Tomoyuki Kamamoto, Yuto Nakajima, Yumiko Uchida, Takashi Nakagawa, Hitoshi Tonegawa, Yuki Tani, Eri Nishimoto, Yukihiro Takahashi, Toshiya Nishikubo, Keiji Nogami
Protein C system in preterm babies with chronic lung disease: Prospective study. Pediatrics international : official journal of the Japan Pediatric Society 64 (1) (2022)
Yuto Nakajima, Eisuke Takami, Hirotoshi Nakano, Keiji Nogami
In vitro evaluation of global coagulation potentials in the co-presence of plasma-derived factors Viia/X products (Byclot ® ) and emicizumab in patients with haemophilia A and inhibitors and acquired haemophilia A: A pilot study. Haemophilia : the official journal of the World Federation of Hemophilia 28 (5) (2022)
Yuya Yamada, Yuto Nakajima, Ayaka Ohara, Emi Wakita, Kazuki Shimizu, Naruto Shimonishi, Shoko Furukawa, Kenichi Ogiwara, Masahiro Takeyama, Keiji Nogami
Two pediatric cases of severe hemophilia A in which emicizumab prophylaxis failed to prevent traumatic extra-articular hemorrhage. International journal of hematology (2022)
Yuto Nakajima, Kuniyoshi Mizumachi, Naruto Shimonishi, Shoko Furukawa, Koji Yada, Kenichi Ogiwara, Masahiro Takeyama, Midori Shima, Keiji Nogami
Comparisons of global coagulation potential and bleeding episodes in emicizumab-treated hemophilia A patients and mild hemophilia A patients. International journal of hematology 115 (4) (2022)
Yuto Nakajima, Masahiro Takeyama, Akihisa Oda, Naruto Shimonishi, Keiji Nogami
Factor VIII mutated with Lys1813Ala within the factor IXa-binding region enhances intrinsic coagulation potential. Blood advances (2022)